GinaGee-HeeChungMD
Hematology • Cincinnati, OHHematologic Oncology
Assistant Professor, Comprehensive Cancer Center, Yale University School of Medicine
Dr. Chung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5885 Harrison Ave
Cincinnati, OH 45248Phone+1 513-588-5655Fax+1 513-588-5651
Education & Training
Yale-New Haven Medical CenterFellowship, Medical Oncology, 1999- Yale-New Haven Medical CenterResidency, Internal Medicine, 1994 - 1997
Stanford University School of MedicineClass of 1994
Certifications & Licensure
IN State Medical License 2020 - 2025
KY State Medical License 2018 - 2025
OH State Medical License 2018 - 2025
CT State Medical License 1997 - 2019- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer Start of enrollment: 2007 Mar 01
- Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib Start of enrollment: 2012 Apr 27
- Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 622 citationsAutomated subcellular localization and quantification of protein expression in tissue microarrays.Robert L. Camp, Gina G. Chung, David L. Rimm
Nature Medicine. 2002-10-21 - 123 citationsExercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trialsLisa Cadmus, Peter Salovey, Herbert Yu, Gina G. Chung, Stanislav V. Kasl
Psycho-Oncology. 2009-04-01 - 44 citationsTissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.Peter S. Yoo, Catherine A.W. Sullivan, Sharon C. Kiang, Wenli Gao, Edward Uchio
Annals of Surgical Oncology. 2009-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
